[1] Chaudhary, S., Garg, T., Murthy, R. S., Rath, G., Goyal, A. K., "Recent approaches of lipid- based delivery system for lymphatic targeting via oral route", J. Drug Target, 22, pp. 1 –12, (2014).
[2] Garg, T., Singh, O., Arora, S. Murthy, R.," Scaffold: a novel carrier for cell and drug delivery", Crit Rev Ther Drug Carrier Syst., pp. 29, 1–63, (2012).
[3] Utreja, P., Jain, S., Tiwary, A. K., "Novel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: current status and future prospects", Curr. Drug Deliv., 7, pp. 152-61, (2010).
[4] Tarun Garg., Onkar Singh., Saahil Arora, R. S. R. Murthy., Scaffold: "A Novel Carrier for Cell and Drug Delivery", Crit. Rev. Ther. Drug, 29, pp. 1–63, (2012).
[5] Farhana, S. A., Shantakumar, S. M., Shyale, S., et al., "Sustained release of verapamil hydrochloride from sodium alginate microcapsules", Curr. Drug Deliv., 7, pp. 98–108, 2010.
[6] Hench, L. L., "Bioceramics", J Am Ceram Soc., 81, pp. 1705-28, (1998).
[7] Subramanian, A., Krishnan, U. M., Sethuraman, S., "In vivo biocompati-bility of PLGA-polyhexylthiophene nanofiber scaffolds in a rat model", Biomed. Res. Int., pp. 390–518, (2013).
[8] Girlich, C., Scholmerich J., "Topical delivery of steroids in inflam- matory bowel diseas, Curr", Drug Deliv., 9, pp. 345–349, (2012).
[9] Babensee, J. E., Mikos, A. G., Anderson, J. M. McIntire, L. V., "Host response to tissue engineered devices", Adv Drug Del Rev., pp. 33, 111-39, (1998).
[10] Abdelkader, H., Alany, R. G., "Controlled and continuous release ocular drug delivery systems: pros and cons", Curr. Drug Deliv., 9, pp. 421–430, (2012).
[11] Sarvari, R., Sattari, S., Massoumi, B., Agbolaghi,
S., Beygi-Khosrowshahi, Y., Kahaie-Khosrowshahi, A., "Composite electrospun nanofibers of reduced graphene oxide grafted with poly
(3-dodecylthiophene) and poly (3-thiophene ethanol) and blended with polycaprolactone", J. Biomater. Sci., Polym. Ed., 28, pp. 1740–1761, (2017).
[12] Basile, L., Pignatello, R., Passirani, C., "Active targeting strategies for anticancer drug nanocarriers", Curr. Drug Deliv., 9, pp. 68–255, (2012).
[13] Sarvari, R., Akbari-Alanjaraghi, M., Massoumi, B., Beygi-Khosrowshahi, Y., Agbolaghi, S., "Conductive and biodegradable scaffolds based on a five-arm and functionalized star-like polyaniline–polycaprolactone copolymer with ad-glucose core", New J. Chem., 41, pp. 6371–6384, (2017).
[14] Cheung, H., Lau, K., Lu, T., Hui, D., "A critical review on polymer-based bio-engineered materials for scaffold development", Composites B: Eng., 3, pp. 291–300, (2007).
[15] Liuyun, J., Yubao, L., Chengdong, X., "Preparation and biological properties of a novel composite scaffold of nano-hydroxyapatite/chitosan/ carboxymethyl cellulose for bone tissue engineering", J. Biomed. Sci., 16, p. 65, (2009).
[16] Vunjak-Novakovic, G., Freed, L. E., "Culture of organized cell communities, Adv. Drug Deliv", Rev., 33, pp. 15–30, (1998).
[17] Marwah, H., Garg, T., Goyal, A. K., Rath, G., "Permeation enhancer strategies in transdermal drug delivery", Drug Deliv., pp. 1–15, (2014).
[18] Kaur R., Garg T., Malik B., et al., "Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs", Drug. Deliv., pp. 1–6, (2014).
[19] Kaur, R., Garg, T., Das Gupta, U., Gupta, P., Rath, G., Goyal, A. K., "Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs”, Artif. cells, Nanomed., and Biotechnol., 44, pp. 182–187, (2016).
[20] Sarvari, R., Massoumi, B., Zareh, A., Beygi-Khosrowshahi, Y., Agbolaghi, S., “Porous conductive and biocompatible scaffolds on the basis of polycaprolactone and polythiophene for scaffolding”, Poly. Bull., pp. 1–18, (2019).
[21] Massoumi, B., Sarvari, R., Zareh, A.,
Beygi-Khosrowshahi, Y., Agbolaghi, S., "Polyanizidine and Polycaprolactone Nanofibers for Designing the Conductive Scaffolds”, Fibers Polym., 19, pp. 2157–2168, (2018).
[22] Babu, R. J., Sathigari, S., Kumar, M. T., Pandit, J. K., "Formulation of controlled release gellan gum macro beads of amoxicillin", Curr. Drug Deliv., 7,
pp. 36–43, (2010).
[23] Lyons, F., Partap, S., O’Brien, F. J., Part 1: "scaffolds and surfaces, Technol. Health Care", 16, pp. 17–305, (2008).
[24] Sarvari, R., Agbolaghi, S., Beygi-Khosrowshahi, Y., Massoumi, B., Bahadori, A., "3D Scaffold Designing based on Conductive/Degradable Tetrapolymeric Nanofibers of PHEMA-co-PNIPAAm-co-PCL/PANI for Bone Tissue Engineering", Journal of Ultrafine Grained and Nanostructured Materials, 51,
pp. 101–114, (2018).
[25] Chung, H. J., "Park TG. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering". Adv Drug Deliv Rev., 59, pp. 249-59, (2007).
[26] Garg, T., Rath, G., Goyal, A. K., "Biomaterials-based nanofiber scaffold: targeted and controlled carrier for cell and drug delivery", J. Drug Target, 23, pp. 202–221, (2015).
[27] Ma, Z., Kotaki, M., Inai, R., Ramakrishna, S., "Potential of nanofiber matrix as tissue-engineering scaffolds", Tissue Eng, 11, pp. 101-9, (2005).
[28] Xing, X., Wang, Y., Li, B., "Nanofibers drawing and nanodevices assembly in poly (trimethylene terephthalate)", Opt. Express, 16, pp. 10815–10822, (2008).
[29] Cheng, F., Tang, W., Li, Ch., Chen, J., Liu, H., Shen, P., Dou, Sh., "Conducting poly(aniline) nano-tubes and nanofibers: controlled synthesis and application in lithium/poly(aniline) rechargeable batteries”, Chemistry, 12, 3082–3088, (2006).
[30] Paquay, Y. C., de Ruijter, A. E., van der Waerden, J. P., Jansen J. A., "A one stage versus two stage surgical technique. Tissue reaction to a percutaneous device provided with titanium fiber mesh applicable for peritoneal dialysis", ASAIO J, 42, pp. 7–961, (1996).
[31] Lavik, E., Langer, R., "Nerve regeneration, in scaffolding in tissue engineering", Ma P, Elisseeff J (eds). CRC Press, pp. 481–499, (2005).
[32] Badrossamay, M. R., McIlwee, H. A., Goss, J. A., Parker, K. K., "Nanofiber assembly by rotary
jet- spinning", Nano Lett., 10, pp. 2257–2261, (2010).
[33] Cima, L. G., Vacanti, J., Vacanti, C., Ingber, D., "Mooney D. and Langer R., Tissue engineering by cell-44 transplantation using degradable polymer substrates", J. Biomech. Eng., 113, pp. 143–151, (1991).
[34] Kim, B. S., Mooney, D. J., "Engineering smooth muscle tissue with a predefined structure", J. Biomed. Mater. Res. A, 41, pp. 322–332, (1998).
[35] Ko, Y. G., Chen, G., "Development of polymeric porous scaffolds using an ice particulate template for tissue engineering", PhD Thesis, University of Cincinnati, (2010).
[36] Yang, S., Leong, K., Du, Z., Chua C., "The design of scaffolds for use in tissue engineering", Part II. Rapid- prototyping techniques, Tissue Eng., 8,
pp. 1–11, (2002).
[37] Sachs, E., Curodeau, A., Fan, T., Bredt, J., Cima, M., Brancazio, D., "Three dimensional printing system", US Patent, p. 5807437, (1998).
[38] Sanders, Jr R., Forsyth, J., Philbrook, K., "3-D model maker", US Patent, p. 5506607, (1996).
[39] Hull, C., "Method for production of threedimensional objects by stereolithography", US Patent, p. 4929402, (1990).
[40] Crump, S., "Apparatus and method for creating
three-dimensional objects", US Patent, p. 5121329, (1992).
[41] Sachlos, E., Czernuszka, J. T., "Making tissue engineering scaffolds work. Review on the application of solid freeform fabrication technology to the production of tissue engineering scaffolds", Europ. Cells Mater., 5, pp. 29–40, (2003).
)